CMI_LatestReportOrientedBlogs

  Cardiac Biomarkers  Cardiac biomarkers are circulating proteins that are produced by the heart. They are produced when tissue damage or necrosis occurs in the heart, such as in myocardial infarction. Myoglobin is one such protein and it is not specific to myocardial infarction. Creatine kinase and troponin are also detected in blood within 3-4 hours of myocardial infarction. Myoglobin is a hemeprotein found in both skeletal and cardiac muscle. Myoglobin levels increase first in the heart, which is why Cardiac Biomarkers are considered early markers of heart attack. However, myoglobin increases after noncardiac trauma and may not be used alone as a marker for heart attacks. So, it may not be the best choice as a sole marker. To determine whether a certain biomarker is present in the blood, it is important to identify its level and the underlying cause. Using several biomarkers can increase the sensitivity and specificity of the test. Multiple biomarkers are particularly useful for

  Veterinary Infusion Pump Controlled analgesia veterinary infusion pumps are commonly used in healthcare settings and are widely used to transfer medications, nutrients, and fluids inside the patient body at regular intervals in accurate dosages. The infusion of medication into the veterinaries plays a vital role in current therapeutic regimens. They are used across the healthcare settings right from inpatient, outpatient, and private clinics to at-home settings. Veterinary infusion pumps have revolutionized the administration of intravenous medications with programmed features such as intermittent and preprogramming, bolus dosing, and standby mode. By Veterinary Infusion Pump Market Report Controlled analgesia veterinary infusion pumps are commonly used in healthcare settings and are widely used to transfer medications, nutrients, and fluids inside the patient body at regular intervals in accurate dosages. The infusion of medication into the veterinaries plays a vital role in curr